Skip to main content
. Author manuscript; available in PMC: 2014 Jul 2.
Published in final edited form as: J Immunother. 2008 Nov-Dec;31(9):885–895. doi: 10.1097/CJI.0b013e3181880f1e

Figure 1. Intratumoral dendritic cell vaccination augments the anti-tumor effects of chemoradiation.

Figure 1

Mice bearing 7-day subcutaneous SCCVII tumors (2.5 × 105 cells) were treated with 2 days of systemic cisplatin (4 mg/kg) and 5-fluorouracil (50 mg/kg) and 5 days of fractionated radiation to the flank tumor site (3 Gy/day; 15 Gy total). Mice were given three weekly intratumoral injections of dendritic cells (1 × 106/injection) beginning on the first day of chemoradiation. The number of long-term surviving mice with complete tumor regression are indicated. (*) p < 0.05 compared to HBSS.